2024-02-01 2025-01-31 false Capium Accounts Production 1.1 11781923 2024-02-01 2025-01-31 11781923 bus:AbridgedAccounts 2024-02-01 2025-01-31 11781923 bus:FRS102 2024-02-01 2025-01-31 11781923 bus:AuditExemptWithAccountantsReport 2024-02-01 2025-01-31 11781923 bus:SmallCompaniesRegimeForAccounts 2024-02-01 2025-01-31 11781923 bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 11781923 2024-02-01 2025-01-31 11781923 2025-01-31 11781923 bus:RegisteredOffice 2024-02-01 2025-01-31 11781923 core:WithinOneYear 2025-01-31 11781923 core:AfterOneYear 2025-01-31 11781923 1 2024-02-01 2025-01-31 11781923 bus:Director1 2024-02-01 2025-01-31 11781923 bus:Director1 2025-01-31 11781923 bus:Director1 2023-02-01 2024-01-31 11781923 bus:Director2 2024-02-01 2025-01-31 11781923 bus:Director2 2025-01-31 11781923 bus:Director2 2023-02-01 2024-01-31 11781923 2023-02-01 11781923 bus:LeadAgentIfApplicable 2024-02-01 2025-01-31 11781923 2023-02-01 2024-01-31 11781923 2024-01-31 11781923 core:WithinOneYear 2024-01-31 11781923 core:AfterOneYear 2024-01-31 11781923 bus:EntityAccountantsOrAuditors 2023-02-01 2024-01-31 11781923 core:NetGoodwill 2024-02-01 2025-01-31 11781923 core:NetGoodwill 2025-01-31 11781923 core:NetGoodwill 2024-01-31 11781923 core:CostValuation core:Non-currentFinancialInstruments 2025-01-31 11781923 core:CostValuation core:Non-currentFinancialInstruments 2024-01-31 11781923 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-01-31 11781923 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-01-31 11781923 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-01-31 11781923 core:Non-currentFinancialInstruments 2025-01-31 11781923 core:Non-currentFinancialInstruments 2024-01-31 11781923 core:RetainedEarningsAccumulatedLosses 2025-01-31 11781923 core:RetainedEarningsAccumulatedLosses 2024-01-31 11781923 dpl:Item1 2024-02-01 11781923 dpl:Item1 2025-01-31 11781923 dpl:Item1 2023-02-01 11781923 dpl:Item1 2024-01-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 11781923
England and Wales
SUMEDHA PHARMA LIMITED
Abridged Accounts
Period of accounts Start date: 01 February 2024 End date: 31 January 2025

SUMEDHA PHARMA LIMITED Contents Page For the year ended 31 January 2025
Accountants' report | 1
Statement of financial position | 2
Notes to the financial statements | 3

SUMEDHA PHARMA LIMITED Accountants' Report For the year ended 31 January 2025
Accountant’s report You consider that the company is exempt from an audit for the year ended 31 January 2025 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year. In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us. We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts. Myrtle Gund Ltd 31 January 2025 .................................................... Myrtle Gund Ltd 248 Lockwood Road Huddersfield HD1 3TG 23 January 2026 1

SUMEDHA PHARMA LIMITED Statement of Financial Position As at 31 January 2025
| Notes | 2025 £ |  | 2024 £
--- | --- | --- | --- | ---
Fixed assets |  |  |
Intangible fixed assets | 3 | 352,500 |  | 376,000
|  | 352,500 |  | 376,000
Current assets |  |  |
Stocks |  | 30,000 |  | 30,000
Debtors |  | 139,182 |  | 143,457
Cash at bank and in hand |  | 54,143 |  | 49,358
|  | 223,325 |  | 222,815
Creditors: amount falling due within one year |  | (334,270) |  | (264,783)
Net current assets |  | (110,945) |  | (41,968)
Total assets less current liabilities |  | 241,555 |  | 334,032
Creditors: amount falling due after more than one year |  | (346,019) |  | (416,707)
Net assets |  | (104,464) |  | (82,675)
Capital and reserves |  |  |
Profit and loss account |  | (104,464) |  | (82,675)
Shareholders' funds |  | (104,464) |  | (82,675)
For the year ended 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Directors' responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies. The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A). The financial statements were approved by the board of directors on 23 January 2026 and were signed on its behalf by:
------------------------------- NEHA KANSAL Director
2

SUMEDHA PHARMA LIMITED Notes to the Abridged Financial Statements For the year ended 31 January 2025
General Information SUMEDHA PHARMA LIMITED is a private company, limited by shares, registered in England and Wales, registration number 11781923, registration address 209A SHEFFIELD ROAD, KILLAMARSH, SHEFFIELD, S21 1DX. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company. Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. Taxation Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Current and deferred tax assets and liabilities are not discounted Intangible assets Intangible assets (including purchased goodwill and patents) are amortised at rates calculated to write off the assets on a straight line basis over their estimated useful economic lives. Impairment of intangible assets is only reviewed where circumstances indicate that the carrying value of an asset may not be fully recoverable. Goodwill Acquired goodwill is stated at cost less amortisation. Amortisation is calculated on a straight line basis over the estimated expected useful economic life of the goodwill of 20 years. Stocks Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.
2. | Average number of employees Average number of employees during the year was 7 (2024 : 7).
3. | Intangible fixed assets
Cost | Goodwill |  | Total
| £ |  | £
At 01 February 2024 | 470,000 |  | 470,000
Additions | - |  | -
Disposals | - |  | -
At 31 January 2025 | 470,000 |  | 470,000
Amortisation
At 01 February 2024 | 94,000 |  | 94,000
Charge for year | 23,500 |  | 23,500
On disposals | - |  | -
At 31 January 2025 | 117,500 |  | 117,500
Net book values
At 31 January 2025 | 352,500 |  | 352,500
At 31 January 2024 | 376,000 |  | 376,000
3